Rchr
J-GLOBAL ID：201901011575663998
Update date: Feb. 29, 2024
Moriyama Saya
Moriyama Saya
Affiliation and department：
Research field (1)：
Immunology
Research theme for competitive and other funds (1)：
- 2019 - 2023 インフルエンザウイルス反応性メモリーB細胞の制御機構の解明
Papers (47)：
-
Eriko Morino, Sohtaro Mine, Noriko Tomita, Yukari Uemura, Yosuke Shimizu, Sho Saito, Tetsuya Suzuki, Nobumasa Okumura, Haruka Iwasaki, Junko Terada, et al. Mpox Neutralizing Antibody Response to LC16m8 Vaccine in Healthy Adults. NEJM evidence. 2024. 3. 3. EVIDoa2300290
-
Saya Moriyama, Yuki Anraku, Shunta Taminishi, Yu Adachi, Daisuke Kuroda, Shunsuke Kita, Yusuke Higuchi, Yuhei Kirita, Ryutaro Kotaki, Keisuke Tonouchi, et al. Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants. Nature communications. 2023. 14. 1. 4198-4198
-
Masaru Takeshita, Hidehiro Fukuyama, Katsuhiko Kamada, Takehisa Matsumoto, Chieko Makino-Okamura, Qingshun Lin, Machie Sakuma, Eiki Kawahara, Isato Yamazaki, Tomomi Uchikubo-Kamo, et al. Potent neutralizing broad-spectrum antibody against SARS-CoV-2 generated from dual-antigen-specific B cells from convalescents. iScience. 2023. 26. 6. 106955-106955
-
Taishi Onodera, Nicolas Sax, Takashi Sato, Yu Adachi, Ryutaro Kotaki, Takeshi Inoue, Ryo Shinnakasu, Takayuki Nakagawa, Shuetsu Fukushi, Tommy Terooatea, et al. CD62L expression marks SARS-CoV-2 memory B cell subset with preference for neutralizing epitopes. Science Advances. 2023. 9. 24
-
Taishi Onodera, Nicolas Sax, Takashi Sato, Yu Adachi, Ryutaro Kotaki, Takeshi Inoue, Ryo Shinnakasu, Takayuki Nakagawa, Shuetsu Fukushi, Tommy Terooatea, et al. CD62L expression marks SARS-CoV-2 memory B cell subset with preference for neutralizing epitopes. Science advances. 2023. 9. 24. eadf0661
ｍore...
MISC (1)：
-
宮本翔, 新城雄士, 新城雄士, 上野朗, 菅野隆行, 齊藤慎二, 片野晴隆, 飯田俊, 相内章, 森山彩野, et al. ワクチンブレークスルー感染者におけるSARS-CoV-2変異ウイルスに対する中和抗体誘導要因の探索. 日本ワクチン学会学術集会プログラム・抄録集. 2022. 26th
Return to Previous Page
